Tanja Branko Pejovic MD
Gynecologic Oncology
Associate Professor of Obstetrics & Gynecology, Oregon Health & Sci University
Join to View Full Profile
3181 SW Sam Jackson Park Rd# L466Portland, OR 97239
Phone+1 503-449-7621
Dr. Pejovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tanja Pejovic is an experienced obstetrician-gynecologist based in Portland, OR, specializing in gynecologic oncology. She completed her fellowship and residency at Yale-New Haven Medical Center following her medical education at the University of Belgrade Faculty of Medicine. Dr. Pejovic has participated in clinical trials and published extensively on topics related to ovarian cancer and endometriosis. She has received several honors, including recognition as one of America's Top Doctors and a Fellow of the American Congress of Obstetricians and Gynecologists.
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2000 - 2003- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1996 - 2000
University of Belgrade Faculty of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 2012 - 2026
OR State Medical License 2003 - 2025
WA State Medical License 2004 - 2017
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2013
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Plasmonic Mesoporous Gold-Based SERS Biosensor for Ovarian Cancer-Derived Extracellular Vesicles.Javeria Bashir, Mostafa Kamal Masud, Asep Sugih Nugraha, Chia-Hung Liu, Arya Vasanth
Small. 2025-07-09 - 5 citationsDevelopment and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.Tetiana Korzun, Abraham S Moses, Parham Diba, Ariana L Sattler, Brennan Olson
Small. 2024-10-01 - 9 citationsIntegrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.Eileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, Pei-Chen Peng, Will Rosenow
American Journal of Human Genetics. 2024-06-06
Journal Articles
- Proposal for a Risk-Based Categorization of Uterine CarcinosarcomaFrederick R Ueland, Esther Elishaev, Tanja Pejovic, Todd B Sheridan, Terry Morgan, Joseph L Kelley, Malcolm S Ross, Stephen H Bush, Ardeshir Hakam, Lynda D Roman, Meri..., Annals of Surgical Oncology
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskPatricia A Ganz, Amanda E Toland, Susan M Domchek, Tanja Pejovic, Clinical Cancer Research
- Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer SusceptibilityJulie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, PLoS One
- Join now to see all
Press Mentions
Can a PARP Inhibitor plus Immunotherapy Improve Recurrent Ovarian Cancer Outcomes?June 25th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
